5-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95%, 100mg

4-CHLOROPYRIMIDINE-2-CARBONITRILE, 95.0%, 100mg

L-Lysine 13C6 15N2 Hydrochloride, min. 98% 13C 15N, 100 mg, glass packaging

6-Bromo-4-iodopyridine-3-carboxylic acid, 95+%, 5g

2-(2-Methyl-5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)ethylamine, 98%, 1g

4-(1H-Benzoimidazol-2-yl)-1-phenyl-pyrrolidin-2-one, 95.0%, 2.5g

2,5-dichloro-4-(3-methyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)benzene-1-sulfonic acid, 90+%, 25g

ethyl 7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate, 95%, 5g

7-[(4-methoxyphenyl)methyl]-5-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-d]pyrimidine-4,6-dione, 97%, 500mg

Dimethyl perfluoro-3,6,9-trioxaundecane-1,11-dioate, 98.0%, 100g

3-(Trifluoromethyl)pyrrolidine, 99.0%, 5g

3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, hydrochloride, (2R,3R,4R,5R)-, 98%, 5mg

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole-1-carboxylate, 95.0%, 250mg